Immediate reocclusion following a successful thrombolysis in acute stroke: A pilot study
- 27 May 2003
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 60 (10), 1684-1687
- https://doi.org/10.1212/01.wnl.0000063323.23493.98
Abstract
Immediate reocclusion after successful thrombolysis was angiographically examined in 29 consecutive stroke patients. The reocclusion, which was associated with a high-grade residual stenosis of initially perfused arteries, occurred in four patients. IV abciximab successfully dissolved the thrombus in all four patients. Rapid thrombotic reocclusion after successful thrombolysis is commonly observed in patients after an acute stroke. Administration of abciximab may lead to reperfusion of the reoccluded artery.Keywords
This publication has 10 references indexed in Scilit:
- Rescue treatment with abciximab in acute ischemic strokeNeurology, 2001
- Effects of Abciximab on the Architecture of Platelet-Rich Clots in Patients With Acute Myocardial Infarction Undergoing Primary Coronary InterventionCirculation, 2001
- Disaggregation of In Vitro Preformed Platelet-Rich Clots by Abciximab Increases Fibrin Exposure and Promotes FibrinolysisArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Abciximab Facilitates the Rate and Extent of ThrombolysisCirculation, 1999
- New thrombolytic strategy: bolus administration of tPA and urokinase-fibrinogen conjugate.Journal of Thrombosis and Thrombolysis, 1999
- Mechanism of Rethrombosis After Thrombolytic Therapy: Angioscopic Findings and Investigation of the Coagulation System in DogsAngiology, 1998
- Mechanisms Initiating Platelet Thrombus FormationThrombosis and Haemostasis, 1997
- Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group.Circulation, 1990
- Platelets and Thrombolytic TherapyThe New England Journal of Medicine, 1990
- Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs.JCI Insight, 1988